Search

everythinglearnresearchcommunity

for

Search:↓

Oestrogen and thyrotropin-releasing hormone affect prolactin and its receptor in human skin and hair, suggesting new treatment options for related conditions.

Blocking prolactin increases the activity of secondary hair follicles in cashmere goats.

Prolactin slows down hair growth in mice.

Reduced androgens linked to kinky hair disorder and hair loss; 5a-reductase inhibitors may help.

Prolactin contributes to hair loss by promoting hair follicle shrinkage and cell death.

Prolactin affects hair growth cycles and can cause early hair follicle regression.

Melatonin implants and long daylight hours alter the timing of hormone release and hair growth in mouflon sheep.

Obese and non-obese women with PCOS have higher heart risk markers, especially if they are obese.

Certain gene variations are linked to higher male hormone levels in Chinese women with PCOS and insulin resistance.

Higher levels of the protein Pannexin-1 may play a role in hair loss in women with PCOS.

Hormonal therapies can improve skin issues by adjusting hormone levels, with future advancements promising better results.

The conclusion is that hirsutism should be diagnosed and treated because it affects quality of life and may signal other health problems.

Low prolactin in young women may increase heart and metabolism risks.

A Rathke's cleft cyst caused hormonal imbalances and symptoms in a 68-year-old woman.

Early onset baldness in men may indicate a condition similar to PCOS, linked to heart disease, diabetes, and prostate issues.

Obese women had more testosterone and less acne, but similar hair growth compared to non-obese women.

Spironolactone can reduce hair growth and testosterone in hirsutism, but is less effective than combined treatments.

Women with PCOS have similar bone density to healthy women, but those who are obese have higher bone density at some body sites.

LC-MS/MS is more reliable than immunoassays for diagnosing 21-hydroxylase deficiency.

Two women with very high androgen levels had only slight skin issues, one due to a non-classical adrenal disorder and the other due to an adrenal tumor.

Women aged 21-26 have a higher rate of PCOS.

Idiopathic hirsutism may be linked to increased skin enzyme activity, and new treatments like laser and eflornithine cream show promise.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Vitamin D is needed for metformin to lower prolactin effectively.

Vitamin E helps reduce PCOS symptoms and improves hormonal balance.

Human skin makes sexual hormones that affect hair growth, skin health, and healing; too much can cause acne and hair loss, while treatments can manage these conditions.

Excessive hair growth can be assessed by history, exam, and blood tests, and treated with medication like dexamethasone, birth control pills, and spironolactone.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.